The analysis revealed that tumors harboring ESR1 mutations exhibited significantly elevated transcriptional activity of ESR1 (Supplementary Fig. 2b), while colorectal tumors carrying TCF7L2 mutations showed decreased transcriptional activity of TCF7L2 (Supplementary Fig. 2c). This evidence concerns the gene ESR1 and colorectal neoplasm.